Found 164 matching trials
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
ATOP TRIAL: T-DM1 in HER2 Positive Breast Cancer PHASE2 This research study is studying an investigational drug as a possible treat...
Show More Status
Active Not Recruiting
Location
City of Hope Comprehensive Cancer Center
Learn More & Join Trial
T-DM1 vs Paclitaxel/Trastuzumab for Breast (ATEMPT Trial) PHASE2 This research study is a Phase II clinical trial. Phase II clinical trials ...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function PHASE1 This open-label, parallel group study will evaluate the pharmacokinetics an...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Tucatinib (ONT-380) Combined With Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2+ Breast Cancer PHASE1 The purpose of this study is to determine the maximal tolerated dose (MTD) ...
Show More Location
University of Alabama
Learn More & Join Trial
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers PHASE2 This phase II trial compares the effect of usual treatment of docetaxel che...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
A Study of Trastuzumab Emtansine (T-DM1) in Combination With Docetaxel, and Potentially Pertuzumab, in Participants With Advanced Breast Cancer PHASE1 This is an open-label, multi-center, non-randomized study of the safety and...
Show More Location
Multiple Locations
Learn More & Join Trial
Trastuzumab & Pertuzumab Followed by T-DM1 in MBC PHASE2 In HER2-positive metastatic breast cancer, trastuzumab based treatment is t...
Show More Location
Hopital Sud - Amiens
Learn More & Join Trial
T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial PHASE3 This phase III trial compares the effect of usual treatment with trastuzuma...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer PHASE2 The purpose of this trial is to evaluate efficacy and toxicity of either th...
Show More Status
Active Not Recruiting
Location
Dept. of Oncology, Örebro University Hospital
Learn More & Join Trial